Clinical Trials Browser

Phase 2 × Camurati-Engelmann Syndrome × fresolimumab × Clear all

NCT01401062 2019-03-05

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Phase 2 Completed

23 enrolled 8 charts

Breast Neoplasms, Camurati-Engelmann Syndrome